Травма спинного мозга

Жизнь
после
травмы
спинного
мозга

Оценка влияния лечения эректильной дисфункции на качество жизни больных

Живов Алексей Викторович

Список литературы

1. Бек А. Метод исследования риска аутоагрессивного поведения (шкала SSI) // Методики психологического исследования в клинике / под ред. Л.И. Вассермана. - Л:, 1978. - С. 102-105.

2. Великолуг А.Н. Социальные и клинико-психологические аспекты самоубийств в современном обществе / А.Н. Великолуг, А.Г. Амбрумова, Л.И. Постовалова // Обозрение психиатрии и мед. психологии. - 1997. - № 1. - С. 26-38.

3. Верткин А.Л. Распространенность и клиническое значение эректильной дисфункции у кардиологических больных / А.Л. Верткин, Ю.С. Тополянский, Е.В. Полупанова [и др.] // Консилиум медикум. - 2005. - Т. 7, № 7. - Электрон, ресурс.

4. Зотов М.В. Психофизиологические подходы к изучению, оценке и коррекции суицидальной настроенности при депрессивных и субдепрессивных состояниях // Материалы Всеармейской науч. конф. -СПб., 2001.-С. 24-26.

5. Зотов М.В. Внимание к мотивационно значимым стимулам как основа методического подхода к исследованию мотивации и его реализация на примере оценки суицидальных тенденций / М.В. Зотов, В.М. Петрукович // Современная психология: состояние и перспективы. - М., 2003. - Т. 1. - С. 264-266.

6. Каплан Г.И. Клиническая психиатрия : пер. с англ. : в 2 т. Т. 1 / Г.И. Каплан, Б.Дж. Сэдок. -М. : Медицина, 1994. - 673 с.

7. Карвасарский Б.Д. Неврозы / Б.Д. Карвасарский. - 2-е изд., пере-раб. и доп. - М.: Медицина, 1990. - 576 с.

8. Комолов Н.В. Оптимизация процесса психофизиологического сопровождения лечебного процесса психосоматических больных // Материалы Всеармейской науч. конф., посвящ. 5-летию кафедры военной психофизиологии ВМедА. - СПб., 2003. - С. 58-63.

9. Корзунин В.А. Сравнительная оценка профессионально важных качеств военных врачей в различных условиях деятельности // Материалы Всеармейской науч. конф., посвящ. 5-летию кафедры военной психофизиологии ВМедА. - СПб., 2003. - С. 102-107.

10. Лакин Г.Ф. Биометрия / Г.Ф. Лакин. - Изд. 4-е, перераб. и доп. -М. : Высш. шк., 1990. - 352 с.

11. Литвинцев С.В. Диагностика и профилактика суицидального поведения военнослужащих. (Сообщение 2-е) / СВ. Литвинцев, В.К. Шамрей, В.В. Нечипоренко, И.Г. Попик // Воен.-мед. журн. — 2001.-№9.-С. 22-29.

12. Личко А.Е. Медико-психологическое обследование соматических больных / А.Е. Личко, Н.Я. Иванов // Журн. невропатологии и психиатрии. - 1980. - Вып. 8. - С 1195-1198.

13. Личко А.Е. Методы медико-психологической диагностики соматических больных / А.Е. Личко, Н.Я. Иванов. - Л., 1983. - 208 с.

Н.Лоран О.Б. Климактерические расстройства у мужчин / О.Б. Лоран, А.С Сегал. - М.: OGGI Production, 1998. - 88 с.

15. Маклаков А.Г. Военная психология / под ред. А.Г. Маклакова. -СПб., 2005. - 463 с.

16. Методы исследования в психологии / под ред. Л.И. Вассермана. -СПб., 2001.-334 с.

17. Нечипоренко В.В. Медицинские аспекты агрессивного и суицидального поведения // Военная психиатрия. - СПб., 2001. -С 298-310.

18. Новиков B.C. Теоретические и прикладные основы профессионально-психологического отбора военнослужащих : руководство / B.C. Новиков, А.А. Боченков. - СПб.: ВМедА, 1998. - 188 с.

19. Петрукович В.М. Использования регистрации резервов внимания в диагностике нервно-психической устойчивости человека / В.М. Петрукович, М.В. Зотов // Материалы науч. конф. / ВмедА. -СПб., 2001.-С. 45-46.

20. Попов Ю.В. Система шкал социальной дезадаптации (ШСД) патохарактерологического диагностического опросника для подростков / Ю.В. Попов, Н.Я. Иванов // Саморазрушающее поведение у подростков : сб. науч. тр. - Л., 1991. - С. 118-122.

21. Рейнольде Дж. Методика оценки суицидального риска : (вопросник ASIQ) // Методы исследования в психологии / под ред. Л.И. Вассермана. - М.5 1991. - С. 91-93.

22. Симонов П.В. Эмоциональный мозг / П.В. Симонов. - М. : Наука, 1981.-216 с.

23. Собчик Л.Н. Методы психологической диагностики : метод, руководство. Вып. 1 / Л.Н. Собчик. - М. : Б. и., 1990. - 73 с.

24. Чермянин СВ. Психофизиологическое обеспечение боевой деятельности военнослужащих в условиях локальных войн : автореф. дис. ... д-ра мед. наук / СВ. Чермянин. - СПб., 1998. - 48 с.

25. Щеплев П.А. Реконструктивная и эстетическая хирургия полового члена : автореф. дис. ... д-ра мед. наук / П.А. Щеплев. - М., 1996. -58 с.

26. Abolfotouh M.A. Effect of erectile dysfunction on quality of life / M.A. Abolfotouh, N.S. al-Helali // East Mediterr Health J. - 2001. -Vol. 7,N3.-P. 510-518.

27. Althof S.E. EDITS: Development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction / S.E. Althof, E.W. Corty, S.B. Levine [et al.] // Urology. - 1999. - Vol. 53, N 4. -P. 793-799.

28. Althof S.E. Treatment responsiveness of the self-esteem and relationship questionnaire in erectile dysfunction / S.E. Althof, J.C. Cappelleri, A. Shpilsky [et al.] // Urology. - 2003. - Vol. 61, N 5. - P. 888-892.

29. AUA guideline on the management of erectile dysfunction: diagnosis and treatment recommendations. - Baltimore : American Urological Association, 2005. - 253 p.

30. Auerbach S.M. Simultaneous administration of vardenafil and tamsu-losin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia / S.M. Auerbach, M. Gittelman, A. Mazzu [et al.] // Urology. - 2004. - Vol. 64, N 5. - P. 998-1003.

31. Baldwin K. Under-reporting of erectile dysfunction among men with unrelated urologic conditions / K. Baldwin, P. Ginsberg, R.C. Harkaway // Intern. J. Impot. Res. - 2003. - Vol. 15, N 2. - P. 87-89.

32. Barada J. Successful salvage of sildenafil (Viagra) failures: benefits of patient education and rechallenge with sildenafil // Intern. J. Imp. Res. - 2001. - Vol. 13, suppl. 4. - P. 49.

33. Benevides M.D. Intraurethral application of alprostadil in patients with failed inflatable penile prosthesis / M.D. Benevides, C.C. Carson // J. Urol. -2000. -Vol. 163, N 3. -P. 785-787.

34. Beutel M.E. Epidemiology of sexual dysfunction in the male population / M.E. Beutel, W. Weidner, E. Brahler // Andrologia. - 2006. -Vol. 38,N4.-P. 115-121.

35. Blander D.S. Sex inventories: can questionnaires replace erectile dysfunction testing? / D.S. Blander, R.F. Sanchez-Ortiz, G.A. Broderick // Urology. - 1999. - Vol. 54, N 4. - P. 719-723.

36. Brant M.D. The prosthesis salvage operation: immediate replacement of the infected penile prosthesis / M.D. Brant, J.K. Ludlow, J J. Mulcahy//J. Urol. -1996. -Vol. 155,N1.-P. 155-157.

37. Broderick G.A. Changing practice patterns in erectile dysfunction: a diagnostic algorithm for the new millennium // Adv. Ren. Repl. Ther. - 1999.-Vol. 65N 4.-P. 314-326.

38. Broderick G.A. Color duplex doppler ultrasound: penile blood flow study // Male infertility and sexual dysfunction / by ed. WJ.G. Hellstrom. -New York [etc.], 1997. - Chap. 27. - P. 367-396.

39. Broderick G.A. ED assessment: which patient needs testing and what's useful // Current and future strategies in erectile dysfunction management : AUA postgraduate course. - Baltimore, 2004. - 68 p.

40. Broderick G.A. Management of patients with Peyronie's disease // Male sexual dysfunction : Practical management guidelines. AUA postgraduate course. - Baltimore, 2006. - 46 p.

41.Buvat J. Acceptance, efficacy and preference of sildenafil in patients on long term auto-intracavernosal therapy: a study with follow-up at one year / J. Buvat, A. Lemaire, J. Ratajczyk // Intern. J. Imp. Res. -2002. - Vol. 14, N 6. - P. 483-486.

42. Capelleri J.C. Comparison between sildenafil-treated subjects with erectile dysfunction and control subjects on the self-esteem and relationship questionnaire / J.C. Capelleri, S.S. Bell, S.E. Althof [et al.] // J. Sex. Med. - 2006. - Vol. 3, N 2. - P. 274-282.

43. Carson C.C. Management of prosthesis infections in urologic surgery // Urol. Clin. North. Amer. - 1999. - Vol. 26, N 4. - P. 829-839.

44. Carson C.C. What to do when initial PDE5 inhibitor therapy fails // Contemporary Urology. - 2006. -N 5. - P. 55-65.

45. Carson C.C. The efficacy of sildenafil citrate (Viagra®) in clinical populations: an update / C.C. Carson, L. Burnet [et al.] // Urology. -2002. - Vol. 60, N 2, suppl. 2. - P. 12-27.

46. Carson С.С. Urologic prostheses : the complete practical guide to devices, their implantation, and patient follow-up / ed. C.C. Carson. -New Jersey : Humana press, 2002. - 309 p.

47. Carson C.C. Erectile response with vardenafil in sildenafil nonre-sponders: a multi-centre, double blind, 12-week, flexible dose, placebo-controlled, erectile dysfunction clinical trial / C.C. Carson, D.G. Hatzicristou, S. Carrier [et al.] // Brit. J. Urol. - 2004. - Vol. 94, N9.-P. 1301-1309.

48. Carson C.C. Phosphodiesterase type 5 inhibitors for erectile dysfunction / C.C. Carson, T.F. Lue // BJU Int. - 2005. - Vol. 96, N 3. - P. 257-280.

49. Carson C.C. Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers / C.C. Carson,.R. Shabsigh, S. Segal [et al.] // Urology. - 2005. - Vol. 65, N 2. - P. 353-359.

50. Chiang H.S. 10 years of experience with penile prosthesis implantation in Taiwanese patients / H.S. Chiang, C.C. Wu, T.C. Wen // J. Urol. -2000. - Vol. 163, N 2. - P. 476^80.

51. Cochlin D.L. Urogenital ultrasound : a text atlas / ed. D.L. Cochlin. -New York : Martin Dunitz, 1996. - 375 p.

52. Cookson M.S. Long-term results with vacuum constriction device / M.S. Cookson, P.V.Nadig // I Urol. - 1993. - Vol. 149, N 2. - P. 290-294.

53. Costa P. Erectile dysfunction: knowledge, wishes and attitudes. Results of a French study of 5.099 men aged 17 to 70 / P. Costa, С Avances, L. Wagner // Prog. Urol. - 2003. - Vol. 13, N 2. - P. 85-91.

54. Costabile R.A. Oral trazodone is not effective therapy for erectile dysfunction: a double-blind, placebo controlled trial / R.A. Costabile, M. Spevak // J. Urol. - 1999. - Vol. 161, N 6. -P. 1819-1822.

55. Davis-Joseph B. Accuracy of the initial history and physical examination to establish the etiology of erectile dysfunction / B. Davis-Joseph, L. Tiefer, A. Melman // Urology. - 1995. -Vol. 45, N 3. - P. 498-502.

56. De Boer BJ. Erectile dysfunction in primary care: prevalence and patient characteristics: The ENIGMA study / B.J. De Boer, MiL. Bots, A. Lycklama [et al.] // Intern. J. Impot. Res. - 2004. - Vol. 16, N 3. -P. 214-219.

57. De Rose A.F. Combined oral therapy with sildenafil and doxazosin for the treatment of non-organic erectile dysfunction refractory to sildenafil monotherapy / A.F. De Rose, M. Giglio, P. Traverso [et al.] // Intern. J. Imp. Res. - 2002. - Vol. 14, N 1. - P. 50-53.

58. De Tejada LS. Therapeutic strategies for optimizing PDE-5 inhibitor therapy in patients with erectile dysfunction considered difficult or challenging to treat // Intern. J. Imp. Res. - 2004. - Vol. 16, suppl. 1. -P. 40-42.

59. Dean J. Erectile dysfunction and sexual satisfaction: new perspectives / J. Dean, B.-J. de Boer, A. Grazziotin [et al.] // Europ. Urol. - 2006. -Vol. 5,N 13, suppl. -P. 759-760.

60. Dean J. Effective erectile dysfunction (ED) treatment enables men to enjoy better sex: the importance of erectile hardness, psychological well-being, and partner satisfaction / J. Dean, B.-J. de Boer, A. Graziottin [et al.] // Europ. Urol. - 2006. - Vol. 5, N 13, suppl. - P. 761-766.

61. Dean J. Partner satisfaction and successful treatment outcomes for men

with erectile dysfunction / J. Dean, B.-J. de Boer, A. Graziottin [et al.] Europ. Urol. - 2006. - Vol. 5, N 13, suppl. - P. 779-785.

62. Dean J. Psychological, social and behavioral benefits for men following effective erectile dysfunction (ED) treatment: men who enjoy better sex experience improved psychological well-being / J. Dean, B.-J. de Boer, A. Graziottin [et al.] // Europ. Urol. - 2006. - Vol. 5, N 13, suppl.-P. 773-778.

63. Dean J. The role of erection hardness in determining erectile dysfunction (ED) treatment outcome / J. Dean, B.-J. de Boer, A. Graziottin [et al.] // Europ. Urol. - 2006. - Vol. 5, N 13, suppl. - P. 767-772.

64. DeBusk R. Management of sexual dysfunction in patients with cardiovascular disease : recommendations of the Princeton Consensus Panel / R. DeBusk, Y. Drory, I. Goldstein [et al.] // Amer. J. Cardiol. - 2000. - Vol. 86, N 2A. - P. 62F-68F.

65. Derby С A. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? / C.A. Derby, B.A. Mohr, I. Goldstein [et al.] // Urology. - 2000. - Vol. 56, N 2. - P. 302-306.

66. Dula E. Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction / E. Dula, S. Bukofzer, R. Perdok, M. George // Europ. Urol. -2001. -Vol. 39, N 5. - P. 558-553.

67. Eardley I. An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction / I. Eardley, P. Wright, R. MacDonagh [et al.] // BJU Int. - 2004. - Vol. 93, N9.-P. 1271-1275.

68. Eardley I. Attitudes toward treatment of erectile dysfunction: results from the MALES study /1. Eardley, R. Rosen, W. Fisher [et al.] // Cur. Med. Res. Opin. -2004. - Vol. 20, N 5. -P. 607-615.

69. Eid J.F. Multicomponent inflatable penile prosthesis: keys to success // Contemp. Urol. -2003. -N 6. -P. 36-48.

70. Feldman H.A. Impotence and it's medical and psychosocial correlates: results of the Massachusetts Male Aging Study / H.A. Feldman, I. Goldstein, D.G. Hatzichristou [et al.] // J. Urol. - 1994. - Vol. 151, N1.-P. 54-61.

71.Flynn RJ. Long-term follow-up of patients with erectile dysfunction commenced on self injection with intracavernosal papaverine with or without phentolamine / RJ. Flynn, G. Williams // Brit. J. Urol. - 1996. -Vol. 78,N4.-P. 628-631.

72. Fulgham P.F. Disappointing initial results with transurethral alprosta-dil for erectile dysfunction in a urology practice setting /P.F. Fulgham, J.S. Cochran, J.L. Denman [et al.] // J. Urol. - 1998. - Vol. 160, N 6, pt. 1.-P. 2041-2046.

73. Gee W.F. Practice trends of American urologists in the treatment of impotence, incontinence and infertility / W.F. Gee, H.L. Holtgrewe, P.C. Albertsen [et al.] // J. Urol. - 1996. - Vol. 156, N 5. - P. 1778-1780.

74. Greco A.E. Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences / A.E. Greco, G. Spera, A. Aversa // Europ. Urol. - 2006. - Vol. 50, N 5. - P. 940-947.

75. Guay A.T. Optimizing response to phosphodiesterase therapy: impact of risk-factor management // J. Androl. - 2003. - Vol. 24, N 6. - P. 59-62.

76. Guay A.T. Clinical experience with intraurethral alrostadil (MUSE) in the treatment of men with erectile dysfunction: a retrospective study. Medicated urethral system for erection / A.T. Guay, J.B. Perez, E. Velasquez [et al.] // Europ. Urol. - 2000. - Vol. 38, N 6. - P. 671-676.

77. Gupta R. Predictors of success and risk factors for attrition in the use of intracavernous injection / R. Gupta, J. Kirschen, R.C. Barrow, 2nd, J.F J. Eid // Urology. - 1997. - Vol. 157, N 5. - P. 1681-1686.

78. Hatzichristou D. Diagnostic steps in the evaluation of patients with erectile dysfunction / D. Hatzichristou, K. Hatzimouratidis, M. Bekas [et al.] // J. Urol. - 2002. - Vol. 168, N 2. - P. 615-620.

79. Hatzichristou D.G. Hemodynamic characterization of a functional erection. Arterial and corporeal veno-occlusive function in patients with a positive intracavernosal injection test / D.G. Hatzichristou, K. Hatzimouratidis, A. Apostolidis [et al.] // Europ. Urol. - 1999. -Vol. 36, N1.-P. 60-67.

80. Hatzichristou D.G. Sildenafil versus intracavernous injection therapy: efficacy and preference in patients on intracavernous injection for more than 1 year / D.G. Hatzichristou, A. Apostolidis, V. Tzortzis [et al.]//J. Urol. - 2000. - Vol. 164, N4.-P. 1197-1200.

81. Hatzichristou D.G. Nocturnal penile tumescence and rigidity monitoring in young potent volunteers: reproducibility, evaluation criteria and the effect of sexual intercourse / D.G. Hatzichristou, K. Hatzimouratidis, E. Ioannides [et al.] // J. Urol. - 1998. - Vol. 159, N6.-P. 1921-1926.

82. Hatzichristou D.G. Current treatments and emerging therapeutic approaches in male erectile dysfunction / D.G. Hatzichristou, E.S. Pescatori // BJU Int. - 2001. - Vol. 88, suppl. 3. - P. 11-17.

83. Heaton J.P. Intracavernosal alprostadil is effective for the treatment of erectile dysfunction in diabetic men / J.P. Heaton, D. Lording, S.N. Liu [et al.] // Intern. J. Impot Res. - 2001. - Vol. 13, N 6. - P. 317-321.

84. Hedon F. Anxiety and erectile dysfunction: a global approach to ED enhances results and quality of life // Intern. J. Impot. Res. - 2003. -Vol. 15,suppl.2.-P. 16-19.

85. Hellstrom WJ. Sustained efficacy and' tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial / WJ. Hellstrom, M. Gittelman, G. Karlin [et al.] // Urology. - 2003. - Vol. 61, N 4, suppl. 1. - P. 8-14.

86. Jiann B.P. Compliance of sildenafil treatment for erectile dysfunction and factors affecting it / B.P. Jiann, C.C. Yu, C.C. Su, J.Y. Tsai // Intern. J. Impot. Res. - 2006. - Vol. 18, N 2. - P. 146-149.

87. Jockenhovel F. Testosterone therapy - what, when and to whom // Aging male. - 2004. - VoL 7, N 4. - P. 319-324.

88. Kattan S. Double-blind randomized crossover study comparing intra-corporeal prostaglandin El with combination of prostaglandin El and lidocaine in the treatment of organic impotence // Urology. - 1995. -Vol. 45,N6.-P. 1032-1036.

89. Kloner R.A. Interaction between the phosphodiesterase 5 inhibitor, ta-dalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men / R.A. Kloner, G. Jackson, J.T. Emmick [et al.] // J. Urol. - 2004. - Vol. 172, N 5, pt. 1. - P. 1935-1940.

90. Kupelian V. Is there a relationship between sex hormones and erectile dysfunction? Results from the Massachusetts Male Aging Study / V. Kupelian, R. Shabshigh, T. Travison [et al.] // J. Urol. - 2006. -Vol. 176, N 6. - P. 2584-2588.

91.Lakin M.M. Intracavernous injection therapy: analysis of results and complications / M.M. Lakin, D.K. Montague, S. VanderBrug Meden-dorp [et al.] // J. Urol. - 1990. - Vol. 143, N 6. - P. 1138-1141.

92. Laumann E.O. The epidemiology of erectile dysfunction: results from the National Health and Social Life Survey / E.O. Laumann, A. Paik, R.C. Rosen // Intern. J. Impot. Res. - 1999. - Vol. 11, suppl 1. - P. 60-64.

93. Lee T. Paraffinoma of the penis / T. Lee, H.R. Choi, T.L Lee, H.Y. Lee // Yonsei Med. J. - 1994. - Vol. 35, N 3. - P. 344-348.

94. Leungwattanakij S. Intracavernosal injection and intraurethral therapy for erectile dysfunction / S. Leungwattanakij, V. Flynn, jr, W.J. Hellstrom // Urol. Clin. North. Amer. - 2001. - Vol. 28, N 2. - P. 343-354.

95.Levine L.A. Vacuum constriction and external erection devices in erectile dysfunction / L.A. Levine, R.G. Dimitriou // Urol. Clin. North. Amer. -2001. -Vol. 28,N2. -P. 335-341.

96. Levine L.A. Mechanical reliability and safety of, and patient satisfaction with the Ambicor inflatable penile prosthesis: results of a 2 center study / L.A. Levine, C.R. Estrada, A J. Morgentaler // Urology. -2001.-Vol. 166,N3.-P. 932-937.

97. Lewis R.W. The MUSE-ACTIS Study Group. Combined use of tran-surethral alprostadil and an adjustable penile constriction band in men with erectile dysfunction: results from a multicentre trial / R.W. Lewis, K. Weldon, K. Nemo // Intern. J. Impot. Res. - 1998. - Vol. 10, suppl. -P. 49.

98. Lewis R.W. External vacuum therapy for erectile dysfunction: use and results / R.W. Lewis, R. Witherington // World J. Urol. - 1997. - Vol. 15,N1.-P. 78-82.

99. Linet O.I. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction / O.I. Linet, F.G. Ogrinc // N. Engl. J. Med. -1996. - Vol. 334, N 14. - P. 873-877.

100. Lizza E.F. Definition and classification of erectile dysfunction : report of the Nomenclature Committee of the International Society of Impotence Research / E.F. Lizza, R.C. Rosen // Intern. J. Impot. Res. — 1999.-Vol. 11,N3.-P. 141-143.

101. Lue T.F. Summary of the recommendations on sexual dysfunctions in men / T.F. Lue, F. Giuliano, F. Montorsi, R.C. Rosen [et al.] // J. Sex. Med. - 2004. - Vol. 1, N 1. - P. 6-23.

102. Lue T.F. Vasculogenic impotence evaluated by high-resolution ul-trasonography and pulsed Doppler spectrum analysis / T.F. Lue, H. Hricak, R.W. Marich [et al.] // Radiology. - 1985. - Vol. 155, N 3. -P. 777-781.

103. Lyngdorf P. Epidemiology study of erectile dysfunction and it's risk factors: a practice based study in Denmark / P. Lyngdorf, L. Hemmingsen // Intern. J. Impot. Res. - 2004. - Vol. 16, N 2. - P. 105-111.

104. Mallis D. Moderate and severe erectile dysfunction equally affects life satisfaction / D. Mallis, K. Moisidis, P.S. Kirana [et al.] // J. Sex. Med. - 2006. - Vol. 3, N 3. - P. 442-449.

105. Martinez R. Clinical experience with apomorphine hydrochloride: the first 107 patients / R.Martinez, A. Puigvert, J.M. Pomerol, R. Rodriguez-Villalba // J. Urol. - 2003. - Vol. 170, N 6, pt. 1. - P. 2352-2355.

106. McAninch J.W. Reconstruction of extensive urethral strictures: circular fasciocutaneous penile flap // J Urol. - 1993. - Vol .149, N 3. -P. 488-491 .

107. McCullough A.R. Achieving treatment optimization with sildenafil citrate (Viagra) in patients with erectile dysfunction / A.R. McCullough, J.H. Barada, A. Fawzy [et al.] // Urology. - 2002. -Vol. 60, N 2, suppl. 2. - P. 28-38.

108. McVary K.T. Sildenafil effects on clinical lower urinary tract symptoms. Presentation at: The Annual Meeting of the Sexual Medicine Society of North America, November 21st, 2005, New York, NY, USA.

109. Meares E.M. Bacteriologic localization patterns in bacterial prosta-titis and urethritis / E.M. Meares, T.A. Stamey // Invest. Urol. - 1968. -Vol. 5,N5.-P. 492-518.

110. Meuleman EJ. Investigation of erectile dysfunction. Diagnostic testing for vascular factors in erectile dysfunction / EJ. Meuleman, W.L. Diemont // Urol. Clin. North. Amer. - 1995. - Vol. 22, N 4. -P. 803-819.

111. Michal V. R. Histological changes An the penile arterial bed with aging and diabetes // Vasculogenic Impotence: Proceedings of the First International Conference on Corpus Cavernosum Revascularization / ed. by A. Zorgniotti and G. Rossi. - Springfield, 1980. - P! 113-119.

112. Mobley D.F. Office evaluation of the impotent man / D.F. Mobley, N.H. Baum // Textbook of andrology / ed. W.J.G. Hellstrom:, - New York : Springer, 1997.-P. 167-185.

113. Montague D. Penile prosthesis in the year 2000 / D.Montague, K. Angermeier. - Baltimore : American Urological Association, 2001. - 38 p. - (AUA Update series. Lesson 31 ; Vol. 19).

114. Montorsi F. Treatment satisfaction in patients with erectile dysfunction switching from prostaglandin E(l) intracavernosal injection therapy to oral sildenafil citrate / F. Montorsi, S.E. Althof, M. Sweeney [et al.] // Intern. J. Imp. Res. - 2003. - Vol. 15, N 6. - P. 444-449:.

115. Montorsi F. Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies / F. Montorsi, Т.Е. McDermott, R. Morgan [et al.] // Urology. - 1999. - Vol. 53, N 5. -P. 1011-1018.

116. Montorsi F. AMS three-piece inflatable implants for erectile dysfunction: a long-term multi-institutional study in 200 consecutive patients / F. Montorsi, P. Rigatti, G. Carmignani [et al.] // Europ. Urol. -2000. -Vol. 37,N 1.-P. 50-55.

117. Montorsi F. The ageing male and erectile dysfunction / F. Montorsi, A. Salonia, F. Deho [et al.] // World J. Urol. - 2002. - Vol. 20, N 1. -P. 28-35.

118. Moore T.M. Erectile dysfunction in early, middle, and late adulthood: symptom patterns and psychosocial correlates / T.M. Moore, J.L. Strauss, S. Herman, C.F. Donatucci // J. Sex. Marital. Ther. -2003. -Vol. 29, N 5. - P. 381-399.

119. Morales A. Hormonal erectile dysfunction: evaluation and management / A. Morales, J.P. Heaton // Urol. Clin. North Amer. - 2001. -Vol. 28, N. 2.-P. 279-288.

120. Moriel E.Z. Sodium bicarbonate alleviates penile pain induced by intracavernous injections for erectile dysfunction / E.Z. Moriel, J. Rajfer // J. Urol. - 1993. - Vol. 149, N 5, pt. 2. - P. 1299-1300.

121. Moyad M.A. Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless. Pt. 2 / M.A. Moyad, J.H. Barada, T.F. Lue [et al.] // Urol. Clin. North Amer. - 2004. - Vol. 31, N 2. - P. 259-273.

122. Moyad MA. Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless. Pt. 1 / M.A. Moyad, J.H. Barada, T.F. Lue [et al.] // Urol. Clin. North Amer. - 2004. - Vol. 31, N 2. - P. 249-257.

123. Mulcahy J.J. Long term experience of salvage of infected penile implants // J. Urol. - 2000. - Vol. 163, N 2. - P. 481-482.

124. Mulcahy J.J. Prevention and correction of penile implant problems // Management of complex penile implant cases Symposium : AUA Annual Meeting handbook. - Baltimore, 1995. - 53 p.

125. Mulhall J.P. Analysis of the consistency of intraurethral pros-taglandin E(l) (MUSE) during at-home use / J.P. Mulhall, A.E. Jahoda, A. Ahmed, M. Parker // Urology. - 2001. - Vol. 58, N 2. -P. 262-266.

126. Munarriz R.M. Experience with the Mentor a-1 / R.M. Munarriz, I. Goldstein // Urologic prostheses : the complete practical guide to devices, their implantation, and patient;follow-up / ed. C.C. Carson. -New Jersey : Humana press, 2002. -P. 191-199.

127. Murad Basar M. A classification based on peak systolic velocity and end diastolic velocity predicts sildenafil citrate success / M. Murad Basar, A. Atan, U.Y. Tekdogan, E. Batislam // Scand. J. Urol. Nephrol. - 2003. - Vol. 37, N 6. - P. 502-506.

128. Mydlo J.H. Use of combined extracorporeal injection and a phos-phodiesterase-5 inhibitor therapy for men with a suboptimal response to sildenafil and/or vardenafil monotherapy after radical retropubic prostatectomy / J.H. Mydlo, R. Viterbo, P/ Crispen // BJU Int. - 2005. -Vol. 95,N6.-P. 843-846.

129. Mydlo J.H. Results from different patient populations using combined therapy with alprostadil and sildenafil: predictors of satisfaction / J.H. Mydlo, M.A. Volpe, RJ. MacChia // BJU Int. - 2000. - Vol. 86, N4.-P. 469-473.

130. Nehra A. Rationale for combination therapy of intraurethral pros-taglandin E(l) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy / A. Nehra, M.L. Blute, D.M. Barrett [et al.] // Intern. J. Imp. Res. - 2002. - Vol. 14, suppl 1. -P. 38^2.

131. Nickel J.C. Research guidelines for chronic prostatitis : consensus report from the first National Institutes of Health International Prostatitis Collaborative Network / J.C. Nickel, L.M. Nyberg, M. Hennenfent // Urology. - 1999. - Vol. 54, N 2. - P. 229-233.

132. NIH Consensus Conference. Impotence. Consensus development panel on impotence // JAMA. - 1993. - Vol. 270, N 1. - P. 83-90.

133. Nolazco C. Prevalence of sexual dysfunctions in Argentina / C. Nolazco, O. Bellora, M. Lopez [et al.] // Intern. J. Imp. Res. - 2004. -Vol. 16, N 1. - P. 69-72.

134. Oesterling J.E. Influence of patient age on the serum PSA concentration: an important clinical observation / J.E. Oesterling, W.H. Cooner, SJ. Jacobsen [et al.] // Urol. Clin. North Amer. - 1993. -Vol. 20,N4.-P. 671-680.

135. Okulate G. Erectile dysfunction: prevalence and relationship to depression, alcohol abuse and panic disorder / G. Okulate, O: Olayinka, A.S. Dogunro // Gen. Hosp. Psych. - 2003. - Vol. 25, N 3. - P. 209-213.

136. Padma-Nathan H. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group [see comments] / H. Padma-Nathan, WJ. Hellstrom, F.E. Kaiser [et al.] // New Engl. J. Med. - 1997. -Vol. 336, N1.-P. 1-7.

137. Park K. Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunction / K. Park, J.H. Ku, S.W. Kim, J.S. Paick // BJU Int. - 2005. - Vol. 95, N 3. - P. 66-70.

138. Perelman M.A. Sex coaching for physicians: combination treatment for patient and partner // Intern. J. Impot. Res. - 2003. - Vol. 15, suppl. 5.-P. 67-74.

139. Perimenis P. A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arterio-genic erectile dysfunction / P/ Perimenis, K. Gyftopoulos, K. Giannitsas [et al.] // Intern. J. Impot. Res. - 2004. - Vol. 16, N 1. -P. 2-7.

140. Porst H. The rationale for prostaglandin El in erectile failure: a survey of worldwide experience // J. Urol. - 1996. - Vol. 155, N3.-P. 802-815.

141. Posner M. Chronometric exploration of mind / M. Posner. — New York ; Oxford : Oxford University Press, 1986. - 124 p.

142. Raina R. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy / R. Raina, M.M. Lakin, A. Agarwal [et al.] // Urology. - 2004. - Vol. 63, N 3. -P. 532-537. -Discussion: p. 538.

143. Rajpurkar A. Comparison of satisfaction rates and erectile function in patients treated with sildenafil, intracavernous prostaglandin El and penile implant surgery for erectile dysfunction in urology practice / A. Rajpurkar, C.B. Dhabuwala // J. Urol. - 2003. - Vol. 170, N 1. -P. 159-163.

144. Rao D.S. Vasculogenic impotence. Arterial and venous surgery / D.S. Rao, C.F. Donatucci // Urol. Clin. North. Amer. - 2001. - Vol. 28, N2.-P. 309-319.

145. Rosen R. Sensitivity of the psychological and interpersonal relationship scales to oral therapies for erectile dysfunction / R. Rosen, G. Broderick, R. Shabsigh [et al.] // J. Sex. Med. - 2005. - Vol. 2, N 4. -P. 461-468.

146. Rosen R.C. Psychogenic erectile dysfunction: classification and management // Urol. Clin. North. Amer. - 2001. - Vol. 28, N 2. -P.269-278.

147. Rosen R.C. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IEEF-5) as a diagnostic tool for erectile dysfunction / R.C. Rosen, J.C. Cappelleri, M.D. Smith [et al.] // Intern. J. Impot. Res. - 1999. - N 11. - P. 319-326.

148. Rosen R.C. Quality of life, mood, and sexual function: a path analytic model of treatment effects in men with erectile dysfunction and depressive symptoms / R.C. Rosen, S.N. Seidman, M.A. Menza [et al.] // Intern. J. Impot. Res. - 2004. - Vol. 16, N 4. - 334-340.

149. Sairam K. Sildenafil influences lower urinary tract symptoms / K. Sairam, E. Kulinskaya, T.A. McNicholas [et al.] // Brit. J. Urol. Int. - 2002. - Vol. 90, N 9. - P. 836-839.

150. Sanchez de la Vega J. Erectile dysfunction in those under 40: etio-logical and contributing factors / J. Sanchez de la Vega, J. Amaya Gutierrez, J.J. Alonso Flores, M. Garcia Perez // Arch. Esp. Urol. -2003. - Vol. 56, N3.-P. 161-164.

151. Sanchez-Cruz J.J. Male erectile dysfunction and health-related quality of life / JJ. Sanchez-Cruz, A. Cabrera-Leon, A. Martin-Morales [et al.] // Europ. Urol. - 2003. - Vol. 44, N 2. - P. 245-253.

152. Sargin S. Dynamic cavernosography in the evaluation of impotence / S. Sargin, A. Esen, A. Ergen [et al.] // Intern. Urol. Nephrol. - 1991. -Vol. 23, N6.-P. 599-604.

153. Sasayama S. Men's health study: current status of erectile dysfunction of 6,112 ambulatory patients at general practitioners offices in Japan / S. Sasayama, N. Ishii, F. Ishikura [et al.] // J. Cardiol. - 2003. -Vol. 42,N2.-P. 57-65.

154. Schwartz E.J. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy / EJ. Schwartz, P. Wong, R.G. Graydon // J. Urol. - 2004. - Vol. 162, N 2, pt. 1. - P. 111-11 A.

155. Scott F.B. Management of erectile impotence: use of implantable inflatable prosthesis / F.B. Scott, W.E. Bradley, D.W. Timm // Urology. - 1973. - Vol. 2, N 1. -P. 80-83.

156. Seftel A.D. Erectile dysfunction in the elderly: epidemiology, etiology and approaches to treatment // J. Urol. - 2003. - Vol. 169, N 6. -P. 1999-2007.

157. Shabshigh R. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone / R. Shabshigh, J.M. Kaufman, C. Steidle [et al.] // J. Urol. - 2004. - Vol. 172, N 2. - P. 658-663.

158. Shiri R. Prevalence and severity of erectile dysfunction in 50 to 75-year-old Finnish men / R. Shiri, J. Koskimaki, M. Hakama [et al.] // J. Urol. - 2003. - Vol. 170, N 6. - P. 2342-2344.

159. Small M.P. Small carrion penile prosthesis: a new implant for the management of impotence / M.P. Small, H.M. Carrion, J.A. Gordon // Urology. - 1975. - Vol. 5, N 4. - P. 479-486.

160. Stamogiannou I. Beliefs about illness and quality of life among men with erectile dysfunction / I. Stamogiannou, E.A. Grunfeld, K. Denison, G. Muir // Intern. J. Impot. Res. - 2005. - Vol. 17, N 2. -P. 142-147.

161. Stanley G.E. Penile prosthetic trends in the era of effective oral erectogenic agents / G.E. Stanley, TJ. Bivalacqua, W.J. Hellstrom // South Med. J. - 2000. - Vol. 76, N 12. - P. 1153-1156.

162. Suetomi T. Evaluation of the effectiveness of sildenafil using questionnaire methods versus audio-visual sexual stimulation / T. Suetomi, F. Endo, H. Takeshima, H. Akaza // Intern. J. Urol. - 2005. - Vol. 12, N4.-P. 369-373.

163. Sundaram C.P. Long-term follow-up of patients receiving injection therapy for erectile dysfunction / C.P. Sundaram, W. Thomas, L.E. Pryor [et al.] // Urology. - 1997. -Vol. 49, N 6. - P. 932-935.

164. Teloken C. Therapeutic effects of high dose yohimbine hydrochlo-ride on organic erectile dysfunction / C. Teloken, E.L. Rhoden, P. Sogari [et al.] // J. Urol. - 1998. - Vol. 159, N 1. - P. 122-124.

165. Thadani U. The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease / U. Thadani, W. Smith, S. Nash [et al.] //J. Amer. Coll. Cardiol. - 2002. - Vol. 40, N 11. - P. 2006-2012.

166. Travison T.G. The natural progression and remission of erectile dysfunction: results from the Massachusetts Male Aging Study / T.G. Travison, R. Shabsigh, A.B. Araujo [et al.] // J. Urol. - 2007. -Vol. 177, N1.-P. 241-246.

167. Vardi Y. Effects of sildenafil citrate (Viagra) on hemodynamic parameters during exercise testing and occurrence of ventricular arrhythmias in patients with erectile dysfunction and cardiovascular disease / Y. Vardi, M. Bulus, S. Reisner [et al.] // Europ. Urol. - 2003. -Vol. 43,N 5. -P. 544-551.

168. Vardi Y. Logistic regression and survival analysis of 450 impotent patients treated with injection therapy: long-term dropout parameters / Y. Vardi, E. Sprecher, IJ. Gruenwald // Urology. - 2000. - Vol. 163, N2.-P. 467-470.

169. Virag R. Intracavernous injection of papaverine for erectile failure // Lancet. - 1982. - Vol. 23, N 2. - P. 938.

170. Webster LJ. Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association classes П and III congestive heart failure: a prospective, placebocontrolled, double-blind crossover trial / L J. Webster, E.D. Michelakis, T. Davis, S.L. Archer // Arch. Intern. Med. - 2004. -Vol. 164,N5.-P. 514-520.

171. Wespes E. Guidelines on erectile dysfunction / E. Wespes, E. Amar, D. Hatzichristou [et al.] // Europ. Urol. - 2002. - Vol. 41, N l.-P. 1-5.

172. Wespes E. Guidelines on erectile dysfunction / E. Wespes, E. Amar, D.G. Hatzichristou [et al.]. - Amsterdam : European Association of Urology, 2006. - 27 p.

173. Wespes E. Age related changes in the quantification of the intra-cavernous smooth muscle in potent men / E. Wespes, P. Moreira de Goes, C.C. Schulman // J. Urol. - 1998. - Vol. 159. - P. 99 (abstract).

174. Wespes E. Sildenafil non-responders: haemodynamic and mor-phometric studies / E. Wespes, A. Rammal, С Garbar // Europ. Urol. -2005.-Vol. 48,N l.-P. 136-139.

175. Wespes E. Venous impotence: pathophysiology, diagnosis and treatment / E. Wespes, С Schulman // J. Urol. - 1993. - Vol. 149, N 5, pt.2.-P. 1238-1245.

176. Williams J.M.G. Cry of pain: understanding suicide and self-harm / J.M.G. Williams. - London : Penguin, 1997. - 188 p.

177. Wilson S.K. Penile prosthesis implantation: pearls, pitfalls and perils // Male infertility and sexual dysfunction / ed. W.J.C. Hellstrom. -New York, 1997.-P. 545.

178. Wilson S.K. Status of penile implants : AUA postgraduate course HO 231 PG. - Baltimore : AUA Annual Meeting, 2002. - 48 p.

179. Wilson S.K. Comparison of mechanical reliability of original and enhanced Mentor Alpha I penile prostheses / S.K. Wilson, M.A. Cleves, D.R. Delk // J. Urol. - 1999. - Vol. 162, N 3. - P. 715-718.

180. Wilson S.K. Inflatable penile implant infection: predisposing factors and treatment suggestions / S.K. Wilson, J.R. Delk // Management of complex penile implant cases Symposium : AUA Annual Meeting handbook. - Baltimore, 1995. - 53 p.

181. Wilson S.K. Penile implants / S.K. Wilson, J. Mulcahy // Male sexual function / ed by J J. Mulcahy. -Totowa (N. J.) : Humana Press Inc., 2006.-Chap. 16.-P. 331-380.

182. Yassin A.A., Saad F., Traish A. Alfuzosin combined with tadalafil improves tadalafil response. Presentation at: The 6th Congress of European Society of Sexual Medicine, November 16-19, 2003, Istanbul, Turkey.

183. Zhou S.H. Role of female partners in the diagnostics and treatment of erectile dysfunction / S.H. Zhou, J.X. Xie, M. Chen [et al.] // Zhonghua Nan Ke Xue. - 2006. - Vol. 12, N.5. - P. 473-476.

Живов А.В. Оценка влияния лечения эректильной дисфункции на качество жизни больных

Похожие материалы

Дата публикации: 15 января 2017

.



Жизнь после травмы
спинного мозга